ZyVersa Therapeutics (NASDAQ:ZVSA) Upgraded at Wall Street Zen
ZyVersa Therapeutics (NASDAQ:ZVSA – Get Free Report) was upgraded by investment analysts at Wall Street Zen to a “sell” rating in a research note issued on Saturday. ZyVersa Therapeutics Stock Performance Shares of NASDAQ:ZVSA opened at $0.65 on Friday. The company’s 50 day moving average price is $0.66 and its two-hundred day moving average price […]
